Literature DB >> 22932958

Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans.

Orionalda de Fátima Lisboa Fernandes1, Carolina Rodrigues Costa, Ruy de Souza Lino Junior, Marina Clare Vinaud, Lúcia Kioko Hasimoto E Souza, Joelma Abadia Marciano de Paula, Maria do Rosário Rodrigues Silva.   

Abstract

In the present study, the in vitro susceptibility and capsular width from both melanized and non-melanized Cryptococcus neoformans cells in the presence of Pimenta pseudocaryophyllus crude extract were determined. The results were compared with those obtained for voriconazole and amphotericin B. Melanization was obtained in minimal medium broth with the addition of L-dopa, and the antifungal susceptibility tests were performed using the broth microdilution method. Capsular width of 30 cells of each one of the isolates in medium with crude extracts of P. pseudocaryophyllus or voriconazole or amphotericin B at a concentration corresponding to 0.5 times the minimal inhibitory concentration (MIC) was measured, and the mean was calculated. The MICs and minimal fungicidal concentrations (MFCs) for plant extract and voriconazole were identical for both melanized and non-melanized C. neoformans isolates, but for amphotericin, the MFCs for melanized cells were up to 8 times higher than for non-melanized cells. The capsular width of C. neoformans cells was smaller (p < 0.001) in the presence crude extract of P. pseudocaryophyllus and of voriconazole regardless melanization. The findings of capsule alterations of C. neoformans verified in this study provide fertile ways for future research into the effects of antifungal agents on the pathogenesis of cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22932958     DOI: 10.1007/s11046-012-9574-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  19 in total

1.  Antimicrobial activity of Hymenaea martiana towards dermatophytes and Cryptococcus neoformans.

Authors:  Ana Cristina Machado de Souza; Lucilia Kato; Cleuza Conceição da Silva; Amanda Feitosa Cidade; Cecilia Maria Alves de Oliveira; Maria do Rosário Rodrigues Silva
Journal:  Mycoses       Date:  2010-11       Impact factor: 4.377

2.  MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii.

Authors:  Josep M Torres-Rodríguez; Eidi Alvarado-Ramírez; Francisca Murciano; Maite Sellart
Journal:  J Antimicrob Chemother       Date:  2008-03-29       Impact factor: 5.790

3.  Antifungal activity from Ocimum gratissimum L. towards Cryptococcus neoformans.

Authors:  Janine de Aquino Lemos; Xisto Sena Passos; Orionalda de Fátima Lisboa Fernandes; José Realino de Paula; Pedro Henrique Ferri; Lúcia Kioko Hasimoto E Souza; Aline de Aquino Lemos; Maria do Rosário Rodrigues Silva
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-04-12       Impact factor: 2.743

4.  Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological survey.

Authors:  W Meyer; K Marszewska; M Amirmostofian; R P Igreja; C Hardtke; K Methling; M A Viviani; A Chindamporn; S Sukroongreung; M A John; D H Ellis; T C Sorrell
Journal:  Electrophoresis       Date:  1999-06       Impact factor: 3.535

5.  Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.

Authors:  David van Duin; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection.

Authors:  Aron J Mednick; Joshua D Nosanchuk; Arturo Casadevall
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 7.  Emerging fungal diseases.

Authors:  Marcio Nucci; Kieren A Marr
Journal:  Clin Infect Dis       Date:  2005-07-11       Impact factor: 9.079

Review 8.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

9.  Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.

Authors:  Luis R Martinez; Dariush Moussai; Arturo Casadevall
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.

Authors:  B P Currie; A Casadevall
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.